Following a recent successful capital raise by a syndicate of successful VC firms, I am now partnering an early stage biotechnology company who are developing cutting-edge immunotherapies to treat cancer by depleting Tregs. This funding is being used to develop their pre-clinical package up to phase I clinical trials and to further expand their team.
They are searching for a hands-on individual to prepare and launch their pre-clinical development package for their antibody programme. This role will be the project lead for the IND package, toxicology and pharmacology work, conducting experiments and collaborating with their CRO partners and various vendors.
This is a great opportunity to have scientific contribution within a small, growing biotechnology company. For more details please apply ASAP or contact me via email@example.com